We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+9.71%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$54.9B
AUM Growth
-$1.43B
Cap. Flow
-$10.1B
Cap. Flow %
-18.32%
Top 10 Hldgs %
15.84%
Holding
4,613
New
106
Increased
2,539
Reduced
1,420
Closed
185

Sector Composition

Rank Sector Weight
1 Technology 7.73%
2 Financials 5.47%
3 Healthcare 4.96%
4 Consumer Discretionary 4.64%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNCE icon
3976
Vince Holding Corp
VNCE
$77.6M
$12.8K ﹤0.01%
737
+587
+391% +$12.3K
AKRO
3977
DELISTED
Akero Therapeutics
AKRO
$12.5K ﹤0.01%
562
-42
-7% -$869
EVFM
3978
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$12.5K ﹤0.01%
135
+89
+193% +$7.51K
TCI icon
3979
Transcontinental Realty Investors
TCI
$318M
$12.3K ﹤0.01%
308
+31
+11% +$1.04K
TYME
3980
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$12.2K ﹤0.01%
8,717
-6,319
-42% -$7.67K
FSLY icon
3981
Fastly Inc
FSLY
$4.54B
$12.2K ﹤0.01%
607
+299
+97% +$6.3K
LQDA icon
3982
Liquidia Corp
LQDA
$7.01B
$12.2K ﹤0.01%
2,845
+1,355
+91% +$5.44K
EVLO
3983
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$12.1K ﹤0.01%
149
+34
+30% +$3.8K
BWX icon
3984
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$11.9K ﹤0.01%
413
+6
+1% +$172
LEAF
3985
DELISTED
Leaf Group Ltd.
LEAF
$11.9K ﹤0.01%
2,967
+244
+9% +$898
LJPC
3986
DELISTED
La Jolla Pharmaceutical Company
LJPC
$11.8K ﹤0.01%
2,994
-381
-11% -$2.25K
BCEL
3987
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$11.7K ﹤0.01%
757
-66
-8% -$797
PHAS
3988
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$11.5K ﹤0.01%
1,890
+157
+9% +$647
KDNY
3989
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$11.5K ﹤0.01%
1,957
-165
-8% -$897
PSNL icon
3990
Personalis
PSNL
$1.52B
$11.3K ﹤0.01%
1,035
-91
-8% -$947
EYPT icon
3991
EyePoint Inc
EYPT
$1.17B
$11.2K ﹤0.01%
725
+419
+137% +$7.47K
ICD
3992
DELISTED
Independence Contract Drilling, Inc.
ICD
$11.2K ﹤0.01%
563
+176
+45% +$3.14K
MRKR icon
3993
Marker Therapeutics
MRKR
$19.3M
$10.9K ﹤0.01%
379
+35
+10% +$1.27K
RMNI icon
3994
Rimini Street
RMNI
$445M
$10.9K ﹤0.01%
2,810
+637
+29% +$2.55K
ORGO icon
3995
Organogenesis Holdings
ORGO
$233M
$10.8K ﹤0.01%
2,245
+1,724
+331% +$10.9K
CBUS icon
3996
Cibus
CBUS
$144M
$10.8K ﹤0.01%
31
+3
+11% +$753
VNTR
3997
DELISTED
Venator Materials PLC
VNTR
$10.5K ﹤0.01%
2,745
+1,584
+136% +$5.15K
NEXT icon
3998
NextDecade
NEXT
$1.8B
$10.3K ﹤0.01%
1,682
+209
+14% +$1.3K
TEUM
3999
DELISTED
Pareteum Corporation
TEUM
$10.3K ﹤0.01%
23,606
+9,952
+73% +$5.75K
BIB icon
4000
ProShares Ultra NASDAQ Biotechnology
BIB
$88.6M
$10.3K ﹤0.01%
167
-1,826
-92% -$97.4K

Similar funds

BNP Paribas Financial Markets's Q4 2019 Portfolio in Review

As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.

  • BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
  • BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
  • BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
  • BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
  • BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
  • BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.